FY2019 Bangchak Corporation Plc. | 03 Table of Contents 06 09 29 25 27 31 Executive Important Events Summary Business Performance 11 - Refinery & Trading 16 - Marketing 19 - Power Plant 21 - Bio-based
. 5. General Characteristics of the Transaction Transaction Type: Acquisition or Disposal of Assets of Category 2 as classified following the Notification of the Stock Exchange of Thailand Consideration
หรือ โทรสาร 0-2695-9909 3 สารบัญ I. Executive Summary 4 II. สาระของร่างแก้ไขกฎหมายหลกัทรัพย์ 6 4 Executive Summary คณะกรรมการ ก.ล.ต. ในการประชุมคร้ังท่ี 9/2551 เม่ือวนัท่ี 13 สิงหาคม 2551 มีมติเห็นชอบ ใน
Exchange (Baht 58 million). The Consolidated Net Loss stands at Baht 869 million against Baht 431 million due to drop in sales volume and selling prices. Unit : million Baht Q 3/2019 Q 3/2018 Group Revenues
FY2018 Bangchak Corporation Plc. I 2 Table of Content Management Discussion & Analysis of Business Operation 03 Executive Summary 05 Important Events 08 Statement of Income 10 Business Performance 10
Eng_MD&A Final Q3'19 November 13, 2019 Ref: SET-2019-011 Re: Management Discussion and Analysis for Quarter 3’ 2019 Attn. to: President The Stock Exchange of Thailand Filter Vision Public Company
Bangchak Corporation Plc. I 2 03 Table of Contents 06 08 21 24 26 28 Executive Statement Summary of Income Business Performance 8 - Refinery & Trading 13 - Marketing 15 - Power Plant 17 - Bio-based Products
-517-0109-14 Fax 66-2-5170529 February 27, 2017 Subject Management Discussion and Analysis for the year ended December 31, 2016 To Managing Director of Stock Exchange of Thailand Table of Financial Ratio
approval from the Office of the Securities and Exchange Commission (SEC) and the conversion process of CPNRF into CPNREIT is expected to be completed by the end of 2017. Central Pattana Public Company
2020 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results for the first quarter ended 31 March 2020